Assembly Appropriations Will Assess Key Cannabis Bills This Week

Several Senate bills related to cannabis or psychedelics will be taken up by the Assembly Appropriations Committee this week. If the approved, they’ll head to the Assembly floor.

SB 519 (Wiener) would decriminalize possession of psilocybin, psilocyn, dimethyltryptamine (DMT), ibogaine, mescaline, lysergic acid diethylamide (LSD), and MDMA (Ecstasy).

SB 1186 (Wiener) would “prohibit a local jurisdiction from adopting or enforcing any regulation that prohibits the retail sale by delivery within the local jurisdiction of medicinal cannabis to medicinal cannabis patients or their primary caregivers by medicinal cannabis businesses.”

This bill is aimed at expanding access to legal marijuana. Currently, over half of local governments prohibit commercial cannabis within their jurisdictions.

SB 1326 (Caballero) would allow the Governor to enter into agreements with other states for interstate imports and exports of cannabis. This would lay the groundwork for the transportation and delivery of cannabis across state lines.

SB 1097 (Pan) would require new warning labels on cannabis products. Under SB 1097, the state Department of Cannabis Control (DCC) must “adopt regulations to require cannabis and cannabis product labels and inserts to include a clear and prominent warning regarding the risks that cannabis use may contribute to mental health problems, in addition to existing labeling requirements.”

Read more about the above-mentioned bills at Marijuana Moment.